Mereo BioPharma Group plc
Mereo BioPharma Group plc
MREO
Valuace
70
Růst
53
Zdraví
75
Cena
$ 1.80
Dnes
--0.03 (-4.55%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.3B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-89%
ROA
-77%
PE
-2
PS
125
Cena 1R
0-3
⌀ Cena
1.97
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
01-04-2026
Poslední dividenda

Profil

Biofarmaceutická společnost Mereo BioPharma Group plc vyvíjí a komercializuje terapeutické postupy pro léčbu onkologie a vzácných onemocnění ve Spojeném království a na mezinárodní úrovni. Jeho hlavní kandidát na přípravek, etigilimab (OMP-313M32), imunoreceptor protilátek T-buněk s Ig a ITIM doménou, který je v klinické studii fáze 1b pro léčbu nádorů. Společnost také vyvíjí Navicixizumab (OMP-305B83), který dokončil klinické studie fáze 1b pro léčbu pozdní linie karcinomu vaječníků; Acumapimod (BCT- 197), inhibitor MAP kinázy p38, který je v klinických studiích fáze II k léčbě akutní exacerbace chronické obstrukční plicní nemoci; a Leflutrozol (BGS- 649), perorální inhibitor aromatázy k léčbě hypogonadotropního hypogonadismu. Navíc se u něj vyvinou vzácné kandidáty na léčbu onemocnění, včetně Setrusumabu (BPS- 804), nové protilátky pro léčbu nedokonalosti osteogeneze, a Alvelestatu (MPH- 966), malé perorální molekuly, která se nachází v klinické studii fáze II k léčbě nedostatku alfa- 1 antitrypsinu. Společnost spolupracuje s Texaskou univerzitou MD Anderson Cancer Center na hodnocení kandidáta na anti-TIGIT terapeutickou protilátku, etigilimabu. Společnost Mereo BioPharma Group plc byla založena v roce 2015 a sídlí v Londýně ve Spojeném království.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
36
Založení
2019-04-24
Adresa
One Cavendish Place
CEO
Denise Vera Scots-Knight

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016
Total Revenues500.00500.000.0010,000.001,507.0036,464.00393.00-122.000.00-3,285.290.00
Cost of Revenues134.00133.000.002,574.00-936.0017,908.0016,347.0023,608.0022,703.5534,606.6524,562.50
Gross Profit366.00367.000.007,426.002,443.0018,556.00-15,954.00-23,730.00-22,703.55-37,891.94-24,562.50
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.000.00500.000.000.000.000.000.00361.10533.43
Cost of Revenues1.001.00132.000.00271.460.000.000.00216.92172.90
Gross Profit-1.00-1.00368.000.00-271.460.000.000.00144.18360.53
Operating Income TTM 2025202420232022202120202019201820172016
R&D Expenses0.000.000.0017,418.0024,962.0023,559.00-16,347.00-23,608.0022,703.5534,606.6524,562.50
Selling General & Admin Expenses0.000.000.0018,424.0019,543.0015,933.0021,222.0015,909.0012,504.8910,697.1911,616.82
Depreciation & Amortization1,151.691,151.691,088.001,061.001,507.00622.0044.001,954.0037.8036.0832.94
Total Operating Expenses40,473.0040,774.0047,364.0035,842.0044,505.0039,492.0021,222.0015,909.0012,504.8910,697.1911,616.82
Operating Income-40,501.43-40,501.43-47,364.00-28,416.00-43,569.00-20,936.00-37,569.00-39,517.00-35,208.44-45,303.84-36,179.32
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.002,885.873,188.46
Selling General & Admin Expenses0.000.000.000.000.000.000.000.002,456.122,775.54
Depreciation & Amortization529.6954.00298.00270.00271.46282.00257.00275.00240.33242.12
Total Operating Expenses8,390.0010,014.0010,867.0011,202.0014,861.919,373.0012,814.009,900.006,393.217,030.65
Operating Income-8,785.43-10,015.00-10,499.00-11,202.00-15,133.37-9,373.00-12,814.00-9,900.00-5,692.75-6,165.44
Net Income TTM 2025202420232022202120202019201820172016
Interest Income2,169.972,173.003,042.282,131.00696.001.0044.00377.00306.83826.86195.14
Interest Expense254.80255.601,370.582,881.003,361.004,001.006,383.003,496.002,360.651,089.93179.77
Other Expense-3,328.76-3,328.764,111.00-1,582.007,476.0035,177.00-128,881.00-1,601.00-43.86-1,384.232,262.63
IBT-43,830.19-43,830.19-43,253.00-29,998.00-36,093.0014,241.00-166,450.00-41,118.00-37,306.12-46,951.14-33,721.55
Income Tax Expense0.000.000.00-532.00-1,897.001,516.00-2,822.00-6,274.00-5,277.38-8,152.08-5,331.27
Net Income-41,878.00-41,878.00-43,253.00-29,466.00-34,196.0012,725.00-163,628.00-34,844.00-32,028.74-38,799.05-28,390.28
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income421.00500.97589.00659.00881.00983.00559.00617.000.000.20
Interest Expense22.9727.8324.00180.00375.00353.00331.00310.000.000.00
Other Expense-517.762,991.00-4,117.00-1,685.007,582.04-5,628.00559.00949.002,095.07-1,550.11
IBT-9,303.19-7,024.00-14,616.00-12,887.00-7,551.33-15,001.00-12,255.00-8,951.00-5,802.11-6,324.12
Income Tax Expense0.000.000.000.00-570.660.000.000.00244.47235.58
Net Income-7,351.00-7,024.00-14,616.00-12,887.00-6,980.67-15,001.00-12,255.00-8,951.00-6,046.57-6,559.70
Per Share Data TTM 2025202420232022202120202019201820172016
EPS$0.00$0.00$0.00$-0.04$-0.28$0.10$-2.41$-1.95$-2.25$-2.81$-3.17
EPS Diluted$0.00$0.00$0.00$-0.04$-0.28$-0.25$-2.41$-1.95$-2.25$-2.81$-3.17
Shares Outstanding159,423.93159,423.93147,924.85659,453.92120,639.28105,563.7367,790.6317,884.9014,228.9613,802.478,957.98
Diluted Shares Outstanding159,423.93159,423.93147,924.85659,453.92120,639.28111,055.1667,790.6317,884.9014,228.9613,802.478,957.98
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.01$-0.01
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.01$-0.01
Shares Outstanding159,423.93159,989.40159,887.07156,855.88155,145.61154,029.32142,354.34140,054.14691,830.57691,830.54
Diluted Shares Outstanding159,423.93159,989.40159,887.07156,855.88155,145.61154,029.32142,354.16140,052.70691,820.09691,820.09
Current Assets TTM 2024202320222021202020192018201720162015
Cash And Equivalents87,431.0069,802.0057,421.0056,334.0094,296.0023,469.0016,347.0025,041.9550,044.6753,577.5779,681.93
Short Term Investments0.000.000.000.000.000.000.002,500.002,500.000.000.00
Total Cash & ST Investments87,431.0069,802.0057,421.0056,334.0094,296.0023,469.0016,347.0027,541.9552,544.6753,577.5779,681.93
Accounts Receivable2,673.003,250.003,732.002,672.001,820.004,638.0011,977.005,886.278,661.436,098.281,342.70
Inventory0.000.000.000.000.000.000.00-293.33-2,500.00-53,919.690.00
Other Current Assets3,836.001,711.002,607.000.000.000.000.001,360.264,470.7855,021.83253.93
Total Current Assets93,940.0074,763.0063,760.0062,131.0099,323.0029,726.0030,435.0034,495.1563,176.8960,778.0081,278.56
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents48,698.0056,125.0062,483.0069,802.0080,522.0087,431.0048,660.0057,421.0047,065.7042,113.00
Short Term Investments0.000.000.000.000.000.000.000.000.000.00
Total Cash & ST Investments48,698.0056,125.0062,483.0069,802.0080,522.0087,431.0048,660.0057,421.0047,065.7042,113.00
Accounts Receivable0.003,747.002,398.003,250.000.002,673.000.003,732.000.0010,739.00
Inventory0.000.000.000.000.000.000.001,247.000.00-2,846.00
Other Current Assets3,709.001,549.002,018.001,711.006,201.003,836.004,836.002,607.005,195.835,598.91
Total Current Assets52,407.0061,421.0066,899.0074,763.0086,723.0093,940.0053,496.0063,760.0052,261.5254,228.00
Long-Term Assets TTM 2024202320222021202020192018201720162015
Net Property, Plant & Equipment1,323.00984.001,650.001,831.002,530.001,573.0011,558.00148.94153.36173.87204.52
Goodwill0.000.000.000.000.000.000.000.000.000.000.00
Intangible Assets866.00643.001,089.0024,116.0024,564.0031,648.0044,456.0032,632.2333,005.2325,812.9425,812.94
Long-Term Investments0.000.000.000.000.000.000.000.000.000.000.00
Other Long-Term Assets0.000.000.000.000.000.000.000.000.000.000.00
Total Long-Term Assets2,189.001,627.002,739.0025,947.0027,094.0033,221.0056,014.0032,781.1633,158.5925,986.8126,017.46
Total Assets96,129.0076,390.0066,499.0088,078.00126,417.0062,947.0086,449.0067,276.3196,335.4886,764.81107,296.02
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment552.00740.00869.00984.001,224.001,323.001,469.001,650.001,352.441,564.00
Goodwill0.000.000.000.000.000.000.000.000.000.00
Intangible Assets643.00470.00554.00643.00799.00866.00972.001,089.00892.6124,845.00
Long-Term Investments0.000.000.000.000.000.000.000.000.000.00
Other Long-Term Assets0.000.000.000.000.000.000.000.000.001.00
Total Long-Term Assets1,195.001,210.001,423.001,627.002,023.002,189.002,441.002,739.002,245.0526,410.00
Total Assets53,602.0062,631.0068,322.0076,390.0088,746.0096,129.0055,937.0066,499.0054,506.5780,638.00
Current Liabilities TTM 2024202320222021202020192018201720162015
Accounts Payable2,700.002,440.002,346.003,078.002,285.003,333.006,352.004,570.313,024.033,209.122,817.52
Short-Term Debt5,610.006,242.00652.0011,551.00622.00636.0017,725.006,837.881,939.810.000.00
Other Current Liabilities7,156.004,396.005,826.0010,048.001,269.004,596.00354.004,947.044,817.500.000.00
Current Liabilities15,466.0013,848.009,486.0024,677.0012,541.008,565.0029,878.0016,177.539,617.613,209.122,817.52
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable879.001,138.002,924.002,440.001,983.002,700.002,455.002,346.001,922.921,912.26
Short-Term Debt397.00601.00747.006,242.006,287.005,610.005,292.001,304.00534.424,677.09
Other Current Liabilities4,740.005,333.003,456.004,396.005,938.004,859.003,257.005,174.005,317.9515,430.50
Current Liabilities6,016.007,557.007,497.0013,848.0014,208.0015,466.0011,004.009,486.007,775.2917,458.00
Long-Term Liabilities TTM 2024202320222021202020192018201720162015
Long-Term Debt552.00187.005,300.001,222.0016,138.0017,300.0014,691.0014,646.7518,812.513,126.532,798.05
Capital Leases552.00894.001,558.001,688.002,376.001,794.0011,904.000.000.000.000.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.000.00
Total Liabilities17,479.0015,421.0015,962.0026,210.0038,415.0077,918.0046,193.0034,505.5333,851.997,508.075,756.88
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt0.000.000.00187.00394.00552.00727.005,300.004,344.204,641.07
Capital Leases397.00601.00747.00894.001,130.001,231.001,389.001,558.001,277.031,461.00
Def. Tax Liability0.000.000.000.000.000.000.000.000.000.00
Total Liabilities7,004.008,454.008,241.0015,421.0016,210.0017,479.0013,099.0015,962.0013,083.4122,893.00
Total Common Equity TTM 2024202320222021202020192018201720162015
Common Stock3,032.003,059.002,775.001,875.001,755.001,017.00294.00213.72213.29193.0259.22
Retained Earnings-440,836.00-462,883.00-419,630.00-331,164.00-296,968.00-309,693.00-146,065.00-111,220.79-79,315.92-33,579.24-12,188.96
Comprehensive Income-18,278.00-18,849.00-17,485.00137,912.00136,895.00133,225.0047,319.0025,592.6223,359.1712,667.560.00
Total Common Equity78,650.0060,969.0050,537.0061,868.0088,002.00-14,971.0040,256.0032,770.7862,483.4979,256.74101,539.14
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock3,134.003,132.003,132.003,059.003,051.003,032.002,775.002,775.002,274.561,930.00
Retained Earnings-493,667.00-486,643.00-472,027.00-462,883.00-455,837.00-440,836.00-428,581.00-419,630.00-343,953.93-342,194.00
Comprehensive Income-10,910.00-8,643.00-15,290.00-18,849.00-11,104.00-18,278.00-18,283.00-17,485.00-14,331.76141,724.00
Total Common Equity46,598.0054,177.0060,081.0060,969.0072,536.0078,650.0042,838.0050,537.0041,423.1657,745.00
Other TTM 2024202320222021202020192018201720162015
Total Debt6,162.006,429.005,952.0012,773.0016,760.0017,936.0032,416.0021,484.6420,752.323,126.532,798.05
Book Value78,650.0060,969.0050,537.0061,868.0088,002.00-14,971.0040,256.0032,770.7862,483.4979,256.74101,539.14
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.000.000.000.000.000.000.000.000.000.00
Book Value46,598.0054,177.0060,081.0060,969.0072,536.0078,650.0042,838.0050,537.0041,423.1657,745.00
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016
Net Income-36,925.82-41,878.00-43,253.00-29,466.00-36,093.0014,241.00-166,450.00-41,118.00-37,306.12-46,951.14-33,721.55
Depreciation & Amortization1,261.42622.001,088.001,061.00727.00642.001,599.001,577.0037.8036.0832.94
Stock-Based Compensation6,653.977,598.007,390.004,924.003,862.003,302.001,558.001,636.002,189.293,651.906,494.02
Change Working Capital6,709.93-3,210.48-369.00-1,593.001,821.00-1,845.00-3,410.00-7,666.002,408.133,020.66-1,987.60
Change In Accounts Receivable6,037.621,399.26-1,649.00456.000.000.000.000.000.000.000.00
Change In Accounts Payable-894.89-1,378.00146.00-1,263.000.000.000.000.000.000.000.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items7,488.115,897.482,310.003,942.00-9,137.0013,409.005,225.00-429.001,917.65751.65179.77
Cash from Operations-20,493.790.000.00-21,132.00-38,820.00-5,239.00-28,341.00-45,931.00-23,137.11-32,147.97-27,399.55
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-7,351.00-7,024.00-14,616.00-12,887.00-7,046.00-14,999.00-12,255.00-8,951.00-7,708.24-8,002.96
Depreciation & Amortization722.00-11.00298.00270.00274.00282.00257.00275.00361.09368.20
Stock-Based Compensation1,543.000.002,065.002,278.001,515.001,737.002,088.002,050.001,232.191,283.79
Change Working Capital-2,250.04636.00-843.00-514.00857.00-1,381.001,420.00-1,506.003,351.203,203.68
Change In Accounts Receivable-476.470.00-744.00952.00-576.00-226.000.00-477.003,516.203,368.68
Change In Accounts Payable450.350.00-1,951.00362.00843.00-1,065.000.00127.00-1,263.000.00
Change In Inventories0.000.000.000.000.000.000.000.000.000.00
Other Non-cash Items-345.96-910.005,445.002,524.00-5,020.006,842.00586.00141.00644.03673.21
Cash from Operations0.000.000.000.000.000.000.000.00-2,119.73-2,474.09
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016
Capital Expenditure-283.64-20.00-699.000.00-10.00-535.00-16.00-21.00-35.54-2,295.57-3.47
Acquisitions0.000.000.000.000.000.00-354.0010,074.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.00-2,500.000.00
Sales of Investment0.000.000.000.000.000.000.0032,865.000.000.000.00
Other Investing Activities-1,282.360.000.00-419.001,507.00114.001,865.00377.00287.091,051.62376.08
Cash from Investing-1,281.580.000.00-419.001,497.00-421.001,495.0043,295.00251.56-3,743.95372.61
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-1.520.000.00-20.000.000.000.00-700.00415.580.00
Acquisitions0.000.000.000.000.000.000.000.000.000.00
Investments0.000.000.000.000.000.000.000.000.000.00
Sales of Investment0.000.000.000.000.000.000.000.000.000.00
Other Investing Activities0.000.000.000.000.000.000.000.00-292.93-289.43
Cash from Investing0.000.000.000.000.000.000.000.00-292.93-289.43
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016
Debt Repaid-219.070.000.00-3,188.00-937.00-692.00-21,888.00-2,212.000.000.000.00
Debt Issued-2,930.936,429.00477.00-3,633.00-3,050.00-484.007,408.0013,143.36732.3217,625.79328.47
Issuance of Common Stock47,012.260.000.0011,605.000.0078,532.0020,136.000.00273.0615,000.0067,888.82
Repurchase of Common Stock0.000.000.000.000.000.000.00-998.00-306.840.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.000.00
Other Financing Activities9,115.290.000.00-444.00153.00-188.0036,489.00-2,500.00-2,039.5418,743.25467.70
Cash from Financing55,910.940.000.007,973.00-784.0077,652.0034,737.00-5,710.00-2,073.3133,743.2568,356.52
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.000.000.00
Debt Issued397.00-204.00-146.00-5,682.00-252.00519.00143.0067.001,607.80-4,967.80
Issuance of Common Stock0.000.000.000.000.000.000.000.00-2.470.00
Repurchase of Common Stock0.000.000.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.004,569.884,545.41
Cash from Financing0.000.000.000.000.000.000.000.004,569.884,545.41
Cash position TTM 2025202420232022202120202019201820172016
Net Change in Cash36,984.09-28,810.0012,381.00-10,761.00-37,962.0070,827.007,122.00-8,695.00-25,002.73-3,532.9041,329.59
Closing Cash Balance87,431.0040,992.0069,802.0057,421.0056,334.0094,296.0023,469.0016,347.0025,041.9550,044.6753,577.57
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-7,706.00-7,427.00-6,358.00-7,319.00-10,720.00-6,909.0038,771.00-8,761.003,677.043,297.06
Closing Cash Balance40,992.0048,698.0056,125.0062,483.0069,802.0080,522.0087,431.0048,660.002,884.382,702.46
Free Cash Flow TTM 2025202420232022202120202019201820172016
Free Cash Flow-20,777.43-30,991.00-33,533.00-21,551.00-38,830.00-5,774.00-28,357.00-45,952.00-23,172.65-34,443.54-27,403.02
Real Free Cash Flow-27,431.41-38,589.00-40,923.00-26,475.00-42,692.00-9,076.00-29,915.00-47,588.00-25,361.94-38,095.44-33,897.03
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-7,683.52-7,309.00-7,651.00-8,649.00-9,420.00-7,519.00-7,904.00-8,691.00-1,704.15-2,474.09
Real Free Cash Flow-9,226.52-7,309.00-9,716.00-10,927.00-10,935.00-9,256.00-9,992.00-10,741.00-2,936.34-3,757.87
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-1.5-12.1-1.4
P/S124.8576.59.4
P/B1.3125.2
P/FCF-1.6-12.2-1.5
Market cap$0.3$4.0
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0.7 %8.7 %0 %
Debt to Income-0.9 %-15.2 %0 %
Debt to Free cash flow-1.1 %-2970.7 %0 %
Interest expense percentage-0.6 %4.4 %0 %
Current ratio8.7 6.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-89.9 %-99.3 %0 %
ROA-78.1 %-63.3 %0 %
CapEx to Revenue4 %-11.9 %0 %
RaD to Revenue0 %856.2 %0 %
ROEM13,888.9 74206

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin19.1 %12 %0 %
Operating margin-9369.9 %-3061.7 %0 %
Net margin-8301.5 %-3157.6 %0 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding160.0 mil 336.0 mil
Employee count0.0 tis 0.0 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader